Advertisement
Screener

IDEXX LABORATORIES INC /DE (IDXX) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

IDEXX LABORATORIES INC /DE Increase (Decrease) in Accounts Receivable

IDEXX LABORATORIES INC /DE (IDXX) reported Increase (Decrease) in Accounts Receivable of $82.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-04

  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $26.04M, a 12.19% decline year-over-year.
  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $56.81M, a 25.57% increase year-over-year.
  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$13.86M.
  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $7.70M.
  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts receivable for fiscal 2025 was $68.72M, a 143.01% increase from fiscal 2024.
  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts receivable for fiscal 2024 was $28.28M, a 47.50% decline from fiscal 2023.
  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts receivable for fiscal 2023 was $53.87M, a 30.13% increase from fiscal 2022.
  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts receivable for fiscal 2022 was $41.40M, a 24.91% increase from fiscal 2021.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 6 month as first filedIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 9 month as first filedIncrease (Decrease) in Accounts Receivable 12 month
2026-06-30$26.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$82.84M
10-Q · filed 2026-08-04
$68.98M
derived: sum of 3 quarters · filed 2026-08-04
$76.68M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$56.81M
10-Q · filed 2026-05-05
$42.94M
derived: sum of 2 quarters · filed 2026-05-05
$50.64M
derived: sum of 3 quarters · filed 2026-05-05
$80.29M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$13.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20
-$6.17M
derived: sum of 2 quarters · filed 2026-02-20
$23.48M
derived: sum of 3 quarters · filed 2026-08-04
$68.72M
10-K · filed 2026-02-20
2025-09-30$7.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03
$37.35M
derived: sum of 2 quarters · filed 2026-08-04
$82.59M
10-Q · filed 2025-11-03
$54.78M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$29.65M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$74.89M
10-Q · filed 2026-08-04
$47.08M
derived: sum of 3 quarters · filed 2026-08-04
$20.19M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$45.24M
10-Q · filed 2026-05-05
$17.43M
derived: sum of 2 quarters · filed 2026-05-05
-$9.46M
derived: sum of 3 quarters · filed 2026-05-05
$19.68M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31-$27.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20
-$54.70M
derived: sum of 2 quarters · filed 2026-02-20
-$25.56M
derived: sum of 3 quarters · filed 2026-02-20
$28.28M
10-K · filed 2026-02-20
2024-09-30-$26.89M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03
$2.25M
derived: sum of 2 quarters · filed 2025-11-03
$56.09M
10-Q · filed 2025-11-03
$55.40M
derived: sum of 4 quarters · filed 2026-02-20
2024-06-30$29.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04
$82.98M
10-Q · filed 2025-08-04
$82.30M
derived: sum of 3 quarters · filed 2026-02-20
$75.69M
derived: sum of 4 quarters · filed 2026-02-20
2024-03-31$53.84M
10-Q · filed 2025-05-01
$53.16M
derived: sum of 2 quarters · filed 2026-02-20
$46.55M
derived: sum of 3 quarters · filed 2026-02-20
$63.58M
derived: sum of 4 quarters · filed 2026-02-20
2023-12-31-$686.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20
-$7.29M
derived: sum of 2 quarters · filed 2026-02-20
$9.74M
derived: sum of 3 quarters · filed 2026-02-20
$53.87M
10-K · filed 2026-02-20
2023-09-30-$6.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
$10.42M
derived: sum of 2 quarters · filed 2024-10-31
$54.56M
10-Q · filed 2024-10-31
$60.89M
derived: sum of 4 quarters · filed 2025-02-21
2023-06-30$17.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$61.16M
10-Q · filed 2024-08-06
$67.50M
derived: sum of 3 quarters · filed 2025-02-21
$48.76M
derived: sum of 4 quarters · filed 2025-02-21
2023-03-31$44.13M
10-Q · filed 2024-05-01
$50.47M
derived: sum of 2 quarters · filed 2025-02-21
$31.74M
derived: sum of 3 quarters · filed 2025-02-21
$48.00M
derived: sum of 4 quarters · filed 2025-02-21
2022-12-31$6.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21
-$12.40M
derived: sum of 2 quarters · filed 2025-02-21
$3.87M
derived: sum of 3 quarters · filed 2025-02-21
$41.40M
10-K · filed 2025-02-21
2022-09-30-$18.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
-$2.47M
derived: sum of 2 quarters · filed 2023-11-01
$35.06M
10-Q · filed 2023-11-01
$19.15M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$16.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
$53.79M
10-Q · filed 2023-08-01
$37.88M
derived: sum of 3 quarters · filed 2024-02-22
$36.21M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$37.53M
10-Q · filed 2023-05-02
$21.62M
derived: sum of 2 quarters · filed 2024-02-22
$19.95M
derived: sum of 3 quarters · filed 2024-02-22
$15.94M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$15.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$17.58M
derived: sum of 2 quarters · filed 2024-02-22
-$21.59M
derived: sum of 3 quarters · filed 2024-02-22
$33.14M
10-K · filed 2024-02-22
2021-09-30-$1.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
-$5.68M
derived: sum of 2 quarters · filed 2022-11-01
$49.05M
10-Q · filed 2022-11-01
$37.36M
derived: sum of 4 quarters · filed 2023-02-16
2021-06-30-$4.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$50.72M
10-Q · filed 2022-08-02
$39.03M
derived: sum of 3 quarters · filed 2023-02-16
$54.17M
derived: sum of 4 quarters · filed 2023-02-16
2021-03-31$54.73M
10-Q · filed 2022-05-04
$43.05M
derived: sum of 2 quarters · filed 2023-02-16
$58.18M
derived: sum of 3 quarters · filed 2023-02-16
$77.39M
derived: sum of 4 quarters · filed 2023-02-16
2020-12-31-$11.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16
$3.44M
derived: sum of 2 quarters · filed 2023-02-16
$22.66M
derived: sum of 3 quarters · filed 2023-02-16
$60.72M
10-K · filed 2023-02-16
2020-09-30$15.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02
$34.35M
derived: sum of 2 quarters · filed 2021-11-02
$72.41M
10-Q · filed 2021-11-02
$70.43M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-30$19.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$57.28M
10-Q · filed 2021-07-30
$55.30M
derived: sum of 3 quarters · filed 2022-02-16
$42.05M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-31$38.06M
10-Q · filed 2021-05-04
$36.08M
derived: sum of 2 quarters · filed 2022-02-16
$22.84M
derived: sum of 3 quarters · filed 2022-02-16
$27.11M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-31-$1.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
-$15.23M
derived: sum of 2 quarters · filed 2022-02-16
-$10.95M
derived: sum of 3 quarters · filed 2022-02-16
$22.47M
10-K · filed 2022-02-16
2019-09-30-$13.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
-$8.97M
derived: sum of 2 quarters · filed 2020-10-29
$24.45M
10-Q · filed 2020-10-29
$9.81M
derived: sum of 4 quarters · filed 2021-02-12
2019-06-30$4.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$37.70M
10-Q · filed 2020-07-31
$23.06M
derived: sum of 3 quarters · filed 2021-02-12
$23.23M
derived: sum of 4 quarters · filed 2021-02-12
2019-03-31$33.42M
10-Q · filed 2020-04-30
$18.78M
derived: sum of 2 quarters · filed 2021-02-12
$18.95M
derived: sum of 3 quarters · filed 2021-02-12
$30.02M
derived: sum of 4 quarters · filed 2021-02-12
2018-12-31-$14.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12
-$14.47M
derived: sum of 2 quarters · filed 2021-02-12
-$3.40M
derived: sum of 3 quarters · filed 2021-02-12
$18.40M
10-K · filed 2021-02-12
2018-09-30$169.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$11.24M
derived: sum of 2 quarters · filed 2019-10-31
$33.04M
10-Q · filed 2019-10-31
$39.23M
derived: sum of 4 quarters · filed 2020-02-14
2018-06-30$11.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$32.87M
10-Q · filed 2019-08-01
$39.07M
derived: sum of 3 quarters · filed 2020-02-14
$25.39M
derived: sum of 4 quarters · filed 2020-02-14
2018-03-31$21.80M
10-Q · filed 2019-05-01
$27.99M
derived: sum of 2 quarters · filed 2020-02-14
$14.32M
derived: sum of 3 quarters · filed 2020-02-14
$27.29M
derived: sum of 4 quarters · filed 2020-02-14
2017-12-31$6.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14
-$7.48M
derived: sum of 2 quarters · filed 2020-02-14
$5.49M
derived: sum of 3 quarters · filed 2020-02-14
$24.92M
10-K · filed 2020-02-14
2017-09-30-$13.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
-$705.00K
derived: sum of 2 quarters · filed 2018-11-01
$18.72M
10-Q · filed 2018-11-01
$24.63M
derived: sum of 4 quarters · filed 2019-02-15
2017-06-30$12.97M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
$32.40M
10-Q · filed 2018-08-01
$38.31M
derived: sum of 3 quarters · filed 2019-02-15
$31.31M
derived: sum of 4 quarters · filed 2019-02-15
2017-03-31$19.43M
10-Q · filed 2018-05-04
$25.34M
derived: sum of 2 quarters · filed 2019-02-15
$18.34M
derived: sum of 3 quarters · filed 2019-02-15
$20.48M
derived: sum of 4 quarters · filed 2019-02-15
2016-12-31$5.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15
-$1.09M
derived: sum of 2 quarters · filed 2019-02-15
$1.05M
derived: sum of 3 quarters · filed 2019-02-15
$22.55M
10-K · filed 2019-02-15
2016-09-30-$7.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
-$4.86M
derived: sum of 2 quarters · filed 2017-10-31
$16.65M
10-Q · filed 2017-10-31
$15.77M
derived: sum of 4 quarters · filed 2018-02-16
2016-06-30$2.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01
$23.65M
10-Q · filed 2017-08-01
$22.77M
derived: sum of 3 quarters · filed 2018-02-16
$16.66M
derived: sum of 4 quarters · filed 2018-02-16
2016-03-31$21.50M
10-Q · filed 2017-04-28
$20.62M
derived: sum of 2 quarters · filed 2018-02-16
$14.52M
derived: sum of 3 quarters · filed 2018-02-16
$20.21M
derived: sum of 4 quarters · filed 2018-02-16
2015-12-31-$882.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
-$6.98M
derived: sum of 2 quarters · filed 2018-02-16
-$1.30M
derived: sum of 3 quarters · filed 2018-02-16
$50.14M
10-K · filed 2018-02-16
2015-09-30-$6.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01
-$414.00K
derived: sum of 2 quarters · filed 2016-11-01
$51.02M
10-Q · filed 2016-11-01
$46.19M
derived: sum of 4 quarters · filed 2017-02-17
2015-06-30$5.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02
$57.13M
10-Q · filed 2016-08-02
$52.29M
derived: sum of 3 quarters · filed 2017-02-17
$50.97M
derived: sum of 4 quarters · filed 2017-02-17
2015-03-31$51.44M
10-Q · filed 2016-04-29
$46.60M
derived: sum of 2 quarters · filed 2017-02-17
$45.28M
derived: sum of 3 quarters · filed 2017-02-17
$33.36M
derived: sum of 4 quarters · filed 2017-02-17
2014-12-31-$4.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17
-$6.16M
derived: sum of 2 quarters · filed 2017-02-17
-$18.08M
derived: sum of 3 quarters · filed 2017-02-17
$3.63M
10-K · filed 2017-02-17
2014-09-30-$1.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28
-$13.24M
derived: sum of 2 quarters · filed 2015-10-28
$8.46M
10-Q · filed 2015-10-28
$11.62M
derived: sum of 4 quarters · filed 2016-02-17
2014-06-30-$11.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
$9.79M
10-Q · filed 2015-07-30
$12.94M
derived: sum of 3 quarters · filed 2016-02-17
$1.57M
derived: sum of 4 quarters · filed 2016-02-17
2014-03-31$21.71M
10-Q · filed 2015-04-28
$24.86M
derived: sum of 2 quarters · filed 2016-02-17
$13.49M
derived: sum of 3 quarters · filed 2016-02-17
$13.93M
derived: sum of 4 quarters · filed 2016-02-17
2013-12-31$3.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17
-$8.21M
derived: sum of 2 quarters · filed 2016-02-17
-$7.78M
derived: sum of 3 quarters · filed 2016-02-17
$15.95M
10-K · filed 2016-02-17
2013-09-30-$11.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24
-$10.93M
derived: sum of 2 quarters · filed 2014-10-24
$12.79M
10-Q · filed 2014-10-24
$9.56M
derived: sum of 4 quarters · filed 2015-02-17
2013-06-30$439.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25
$24.16M
10-Q · filed 2014-07-25
$20.93M
derived: sum of 3 quarters · filed 2015-02-17
$12.48M
derived: sum of 4 quarters · filed 2015-02-17
2013-03-31$23.72M
10-Q · filed 2014-04-25
$20.49M
derived: sum of 2 quarters · filed 2015-02-17
$12.04M
derived: sum of 3 quarters · filed 2015-02-17
$2.42M
derived: sum of 4 quarters · filed 2015-02-17
2012-12-31-$3.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17
-$11.68M
derived: sum of 2 quarters · filed 2015-02-17
-$21.30M
derived: sum of 3 quarters · filed 2015-02-17
-$3.49M
10-K · filed 2015-02-17
2012-09-30-$8.45M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22
-$18.07M
derived: sum of 2 quarters · filed 2013-10-22
-$255.00K
10-Q · filed 2013-10-22
$8.37M
derived: sum of 4 quarters · filed 2014-02-18
2012-06-30-$9.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-23
$8.19M
10-Q · filed 2013-07-23
$16.82M
derived: sum of 3 quarters · filed 2014-02-18
$8.79M
derived: sum of 4 quarters · filed 2014-02-18
2012-03-31$17.82M
10-Q · filed 2013-04-23
$26.45M
derived: sum of 2 quarters · filed 2014-02-18
$18.41M
derived: sum of 3 quarters · filed 2014-02-18
$28.19M
derived: sum of 4 quarters · filed 2014-02-18
2011-12-31$8.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18
$596.00K
derived: sum of 2 quarters · filed 2014-02-18
$10.38M
derived: sum of 3 quarters · filed 2014-02-18
$24.81M
10-K · filed 2014-02-18
2011-09-30-$8.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-19
$1.75M
derived: sum of 2 quarters · filed 2012-10-19
$16.18M
10-Q · filed 2012-10-19
$16.18M
derived: sum of 4 quarters · filed 2013-02-19
2011-06-30$9.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-20
$24.21M
10-Q · filed 2012-07-20
$24.21M
derived: sum of 3 quarters · filed 2013-02-19
$14.58M
derived: sum of 4 quarters · filed 2013-02-19
2011-03-31$14.43M
10-Q · filed 2012-04-20
$14.43M
derived: sum of 2 quarters · filed 2013-02-19
$4.80M
derived: sum of 3 quarters · filed 2013-02-19
$3.95M
derived: sum of 4 quarters · filed 2013-02-19
2010-12-31-$2.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19
-$9.63M
derived: sum of 2 quarters · filed 2013-02-19
-$10.48M
derived: sum of 3 quarters · filed 2013-02-19
$6.91M
10-K · filed 2013-02-19
2010-09-30-$9.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-21
-$10.48M
derived: sum of 2 quarters · filed 2011-10-21
$6.92M
10-Q · filed 2011-10-21
-$6.92M
10-Q · filed 2010-10-22
$9.20M
derived: sum of 4 quarters · filed 2012-02-17
2010-06-30-$849.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-22
$16.54M
10-Q · filed 2011-07-22
-$16.54M
10-Q · filed 2010-07-23
$18.83M
derived: sum of 3 quarters · filed 2012-02-17
$24.80M
derived: sum of 4 quarters · filed 2012-02-17
2010-03-31$17.39M
10-Q · filed 2011-04-21
$19.68M
derived: sum of 2 quarters · filed 2012-02-17
$25.65M
derived: sum of 3 quarters · filed 2012-02-17
2009-12-31$2.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17
$8.26M
derived: sum of 2 quarters · filed 2012-02-17
$1.16M
10-K · filed 2012-02-17
2009-09-30$5.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-22
-$1.13M
10-Q · filed 2010-10-22
2009-06-30-$7.10M
10-Q · filed 2010-07-23
2008-12-31$10.27M
10-K · filed 2011-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lantheus Holdings, Inc. (LNTH)United States$6.510B26.31
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10